# Treatment of Nonalcoholic Steatohepatitis With Pioglitazone

> **NCT00013598** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 30 (—)

## Conditions studied

- Fatty Liver
- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00013598
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2004-03
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00013598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00013598, "Treatment of Nonalcoholic Steatohepatitis With Pioglitazone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00013598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*